Luna Innovations Inc Revenue Growth Rates (LUNA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Luna Innovations Inc  (NASDAQ: LUNA)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

LUNA's Revenue Growth by Quarter and Year

Luna Innovations Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LUNA Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September 30.63
2nd Quarter June 28.87
1st Quarter March 25.05
FY 84.55

LUNAs Annual Revenue
Luna Innovations Inc's Revenue in the fiscal year 2022 $ 109.50 millions
Luna Innovations Inc's Revenue in the fiscal year 2021 $ 87.51 millions
Luna Innovations Inc's Revenue in the fiscal year 2020 $ 82.68 millions
Luna Innovations Inc's Revenue in the fiscal year 2019 $ 70.52 millions
Luna Innovations Inc's Revenue in the fiscal year 2018 $ 42.92 millions




LUNA Revenue third quarter 2023 Y/Y Growth Comment
Luna Innovations Inc reported Revenue growth of 5.07% year on year in the third quarter 2023, to $ 30.63 millions, this is lower than Luna Innovations Inc's recent average Revenue increase of 19.15%.

Looking into third quarter 2023 results within Medical Laboratories industry 14 other companies have achieved higher Revenue growth. While Luna Innovations Inc' s Revenue increase of 5.07% ranks overall at the positon no. 1796 in the third quarter 2023.


LUNA Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December - 144.79 % -50.02 % 33.21 %
3rd Quarter September 5.07 % 43.38 % -3.42 % 14.28 %
2nd Quarter June 10.36 % -6.37 % 50.38 % 4.32 %
1st Quarter March 11.43 % -14.52 % 53.44 % 15.58 %
FY   - 25.1 % 5.85 % -

Financial Statements
Luna Innovations Inc's third quarter 2023 Revenue $ 30.63 millions LUNA's Income Statement
Luna Innovations Inc's third quarter 2022 Revenue $ 29.15 millions Quarterly LUNA's Income Statement


LUNA Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December - 8.75 % -36.3 % 23.09 %
3rd Quarter September 6.09 % 11.43 % -27.24 % 13.29 %
2nd Quarter June 15.25 % 16.37 % 6.24 % 8.4 %
1st Quarter March -20.98 % 73.59 % 1.51 % -11.88 %
FY (Year on Year)   - 25.1 % 5.85 % -


Back to LUNA Growth rate Comparisons >> Back to LUNA Growth rate Comparisons >>


Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #359
Overall #1796

Revenue Y/Y Growth Statistics
High Average Low
161.97 % 19.15 % -50.03 %
(Mar 31 2016)   (Dec 31 2017)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #15
Healthcare Sector #359
Overall #1796
Revenue Y/Y Growth Statistics
High Average Low
161.97 % 19.15 % -50.03 %
(Mar 31 2016)   (Dec 31 2017)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Luna Innovations Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
87.78 % 6.55 % -42.09 %
(Jun 30 2015)  


LUNA's III. Quarter Q/Q Revenue Comment
Luna Innovations Inc achieved in the III. Quarter 2023 below company average Revenue increase of 6.09% quarter on quarter, to $ 30.63 millions.

Within Medical Laboratories industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Luna Innovations Inc's Revenue growth quarter on quarter, overall rank is 1099.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #229
Overall #1099
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #229
Overall #1099
Revenue Q/Q Growth Statistics
High Average Low
87.78 % 6.55 % -42.09 %
(Jun 30 2015)  


LUNA's III. Quarter Q/Q Revenue Comment
Luna Innovations Inc achieved in the III. Quarter 2023 below company average Revenue increase of 6.09% quarter on quarter, to $ 30.63 millions.

Within Medical Laboratories industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Luna Innovations Inc's Revenue growth quarter on quarter, overall rank is 1099.


Luna Innovations Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 116.24 $ 114.76 $ 112.06 $ 109.50 $ 90.74
Y / Y Revenue Growth (TTM) 28.1 % 40.09 % 33.89 % 25.12 % -9.69 %
Year on Year Revenue Growth Overall Ranking # 3171 # 2907 # 1849 # 2213 # 2799
Seqeuential Revenue Change (TTM) 1.29 % 2.41 % 2.34 % 20.67 % 10.77 %
Seq. Revenue Growth (TTM) Overall Ranking # 2420 # 2192 # 2731 # 2720 # 3257


Cumulative Revenue growth Comment
Assuming the Luna Innovations Inc's fiscal year would have ended in Sep 30 2023, Luna Innovations Inc would have reprted above average annual Revenue rise of 28.1% year on year, of $ 116 millions.
This marks a slow-down of the companys growth trends and from the 40.09% increase in Jun 30 2023.

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2907 to 3171.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 469
Overall # 3171

Revenue TTM Y/Y Growth Statistics
High Average Low
112.78 %
 16.96 %
-31.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 387
S&P 500 # 2420
Cumulative Revenue growth Comment
Assuming the Luna Innovations Inc's fiscal year would have ended in Sep 30 2023, Luna Innovations Inc would have reprted above average annual Revenue rise of 28.1% year on year, of $ 116 millions.
This marks a slow-down of the companys growth trends and from the 40.09% increase in Jun 30 2023.

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2907 to 3171.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 469
Overall # 3171

Revenue TTM Y/Y Growth Statistics
High Average Low
112.78 %
16.96 %
-31.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 387
S&P 500 # 2420




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LUNA's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Beam Therapeutics Inc 8.82%$ 8.823 millions
Glaukos Corp8.80%$ 8.796 millions
West Pharmaceutical Services Inc 8.79%$ 8.793 millions
Idexx Laboratories Inc8.71%$ 8.711 millions
Enovis Corp8.64%$ 8.638 millions
Outset Medical Inc 8.63%$ 8.631 millions
Skinhealth Systems Inc 8.62%$ 8.621 millions
Surgery Partners Inc 8.62%$ 8.621 millions
Hca Healthcare Inc 8.30%$ 8.296 millions
Ultragenyx Pharmaceutical Inc 8.10%$ 8.102 millions
Teladoc Health Inc 7.99%$ 7.988 millions
Align Technology inc 7.83%$ 7.832 millions
Acadia Healthcare Company Inc 7.80%$ 7.795 millions
Vivos Inc7.69%$ 7.692 millions
Pro dex Inc 7.68%$ 7.676 millions
Neuronetics Inc 7.67%$ 7.674 millions
Surmodics Inc 7.63%$ 7.627 millions
Ispecimen inc 7.52%$ 7.523 millions
Zoetis Inc 7.44%$ 7.443 millions
Collegium Pharmaceutical Inc 7.32%$ 7.321 millions
Accuray Incorporated7.25%$ 7.254 millions
Chemed Corporation7.23%$ 7.229 millions
Encision Inc 7.16%$ 7.160 millions
Teva Pharmaceutical Industries Limited7.09%$ 7.093 millions
Aspira Women s Health inc 7.00%$ 6.998 millions
Option Care Health Inc 6.99%$ 6.989 millions
Keenova Therapeutics Plc6.95%$ 6.954 millions
Bausch and Lomb Corp6.90%$ 6.900 millions
Universal Health Services Inc 6.80%$ 6.797 millions
Agenus Inc6.77%$ 6.771 millions


About Luna Innovations Inc Revenue Growth Rates (LUNA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Luna Innovations Inc (CIK 1239819).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001239819-23-000131
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Luna Innovations Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.